Examining time to treatment and the role of school-based health centers in a school-based sexually transmitted infection screening program
METHODS: Urine samples were processed through one laboratory and demographics including age, sex, and race/ethnicity were documented for each specimen. All positive cases of chlamydia and gonorrhea from the 2012–2013 school year were reviewed and median time to treatment was compared for those treated at a SBHC versus those treated elsewhere (e.g. city STI clinic, community health center, private physician).
RESULTS: Overall, 545 students had positive results. Of those who tested positive, the median age was 17 years, 27% were tested in a school affiliated with a SBHC, 70% were female, 92% were African American, 79% had chlamydia,11% had gonorrhea, and 10% had dual infections. Of the 485 (90%) who received treatment, those treated at a SBHC had a faster time to treatment as compared to other providers (median 14 days versus 42 days respectively, p <.001). No demographic variable was significantly associated with treatment at a SBHC versus elsewhere.
CONCLUSION: For students testing positive in the Chicago school-based STI program, time to treatment is accelerated in locations with SBHCs. These findings highlight the beneficial role SBHCs can play in adolescent sexual health promotion.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Evaluate the time to treatment based on treatment provider in a school-based sexually transmitted infection screening program. Describe the role of school-based health centers in a school-based sexually transmitted infection screening program.
Keyword(s): School-Based Health, STDs/STI
Qualified on the content I am responsible for because: One of my current professional areas of focus is school and adolescent health, where I support program staff with their data analysis needs. I performed the analysis for this project.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.